You are Here : Moneycontrol Forum Forum Topics Stocks


Bronze Member

959 Messages

The adverse events that led to a pause in trials evaluating AstraZeneca Plc`s (AZN.L) COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.

12.39 AM Sep 17th
We take the quality of the messages posted on forum as seriously as our articles. Kindly follow our Code of Conduct and refrain from posting any abusive, promotional or gibberish content on forum.


Get your own permanent - nickname

Choose your nickname

Your permanent Nickname can be distinct from your username and no one need know the link between the two.